Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Michael RuzickaSonja WurmLars Hartwin LindnerMartin DreylingMichael von Bergwelt-BaildonStefan BoeckClemens Giessen-JungValeria MilaniHans Joachim StemmlerMarion SubkleweOliver WeigertKarsten SpiekermannPublished in: Infection (2022)
Thrombocytopenia after COVID-19 vaccination should trigger a diagnostic workup to exclude vaccine-induced immune thrombotic thrombocytopenia (VITT) and, if confirmed, VA-ITP should be treated according to current ITP guidelines. Re-vaccination of patients seems feasible under close monitoring of blood counts and using a vaccine that differs from the one triggering the initial episode of VA-ITP.